After rising 47 percent Friday on positive trial results, shares of Peregrine Pharmaceuticals (NASDAQ: PPHM) are tacking ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE